128 related articles for article (PubMed ID: 9355257)
1. Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.
Uzal FA; Nielsen K; Kelly WR
Vet Microbiol; 1997 Sep; 57(2-3):223-31. PubMed ID: 9355257
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
3. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
[TBL] [Abstract][Full Text] [Related]
4. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
Ebert E; Oppling V; Werner E; Cussler K
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
[TBL] [Abstract][Full Text] [Related]
5. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
[TBL] [Abstract][Full Text] [Related]
6. Variability of serum antibody responses of goat kids to a commercial Clostridium perfringens epsilon toxoid vaccine.
Uzal FA; Bodero DA; Kelly WR; Nielsen K
Vet Rec; 1998 Oct; 143(17):472-4. PubMed ID: 9829304
[TBL] [Abstract][Full Text] [Related]
7. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
Rosskopf-Streicher U; Volkers P; Werner E
Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four techniques for the detection of Clostridium perfringens type D epsilon toxin in intestinal contents and other body fluids of sheep and goats.
Uzal FA; Kelly WR; Thomas R; Hornitzky M; Galea F
J Vet Diagn Invest; 2003 Mar; 15(2):94-9. PubMed ID: 12661718
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
Bentancor AB; Halperin P; Flores M; Iribarren F
J Infect Dev Ctries; 2009 Sep; 3(8):624-7. PubMed ID: 19801806
[TBL] [Abstract][Full Text] [Related]
10. Detection of Clostridium perfringens epsilon toxin by ELISA.
Naylor RD; Martin PK; Sharpe RT
Res Vet Sci; 1987 Mar; 42(2):255-6. PubMed ID: 2884704
[TBL] [Abstract][Full Text] [Related]
11. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
Naylor RD; Martin PK; Barker LT
Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
[TBL] [Abstract][Full Text] [Related]
12. Development of a flow cytometric bead immunoassay and its assessment as a possible aid to potency evaluation of enterotoxaemia vaccines.
Buys A; Macdonald R; Crafford J; Theron J
J S Afr Vet Assoc; 2014 Mar; 85(1):977. PubMed ID: 24832497
[TBL] [Abstract][Full Text] [Related]
13. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens.
Lee KW; Lillehoj HS; Park MS; Jang SI; Ritter GD; Hong YH; Jeong W; Jeoung HY; An DJ; Lillehoj EP
Avian Dis; 2012 Mar; 56(1):230-3. PubMed ID: 22545552
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of various enzyme-linked immunosorbent assays for the detection of Clostridium perfringens beta anti-toxins.
Krt B
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):293-7. PubMed ID: 10397314
[TBL] [Abstract][Full Text] [Related]
15. Development of double sandwich ELISA for Clostridium perfringens beta and epsilon toxins.
el Idrissi AH; Ward GE
Vet Microbiol; 1992 Apr; 31(1):89-99. PubMed ID: 1615638
[TBL] [Abstract][Full Text] [Related]
16. Protection of goats against experimental enterotoxaemia by vaccination with Clostridium perfringens type D epsilon toxoid.
Uzal FA; Kelly WR
Vet Rec; 1998 Jun; 142(26):722-5. PubMed ID: 9682431
[TBL] [Abstract][Full Text] [Related]
17. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
Pfahler W; Bisesti E; Pereyra JB; Iribarren F
Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
[TBL] [Abstract][Full Text] [Related]
18. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
Boarer CD; Sojka MG; White VJ; Roeder PL
J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
McClain MS; Cover TL
Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
[TBL] [Abstract][Full Text] [Related]
20. The detection of Clostridium perfringens epsilon antitoxin in rabbit serum by monoclonal antibody based competition ELISA.
Sojka MG; White VJ; Thorns CJ; Roeder PL
J Biol Stand; 1989 Apr; 17(2):117-24. PubMed ID: 2715150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
